Ortin Laboratories Ltd (BSE: 539287) is a Hyderabad, Telangana-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹11 Cr, it ranks #4,977 by market cap among the 6,137 Indian listed companies on FinBizNet, and #82 of 86 in Medicinal Chemicals and Botanical Products. At ₹12.84 (as of 25 Oct 2026), the share price is 39.7% below its 52-week high of ₹21.30 and 20.5% above its 52-week low of ₹10.66. The share price is up 8.4% over one year and down 13.3% over three months.
| Current Price | ₹12.84 |
|---|---|
| Market Cap | ₹11 Cr |
| BSE Code | 539287 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products |
| P/E Ratio | -15.4 |
| Return on Equity | -45.96% |
| Return on Assets | -15.24% |
| 52-Week Range | ₹10.66 – ₹21.30 |
| 1-Year Price Change | +8.4% |
| 3-Month Price Change | -13.3% |
| Beta (1Y) | -0.12 |
| Dividend Yield | 0.00% |
| Headquarters | Hyderabad, Telangana |
| Website | www.ortinlabsindia.com |
| Revenue | ₹0 Cr |
|---|---|
| Net Profit | ₹-0 Cr |
| Net Margin | -3400.0% |
| EPS (Basic) | ₹-0.42 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders; formulations, such as anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, anti-biotics-quinolones, anti-biotic-pencillins, antifungal, cephalosporins, and macrolides. Its formulations also include chemo therapeutics, antacids and anti-ulcerants, anti-spasmodics, calcium and iron preparations, anti-arthritic drugs, protein supplements, enzymes, and vitamins, as well as psychiatry, appetizer, gynaec, and anti-retroviral products. In addition, the company offers active pharmaceutical ingredient (API) intermediates, including anti-retroviral, anti-diabetics, analgesics and antipyretics, anti-biotics, antifungal, antacids and anti-ulcerants, and anti-malarials; and manufactures fine chemi
1. Manufacturing of Pharmaceutical Products-This segment engages in the manufacture and sale of drug intermediates and pharmaceutical products.
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4,21,995 Cr | 36.4 | 14.72% | ₹15,300 Cr | +5.4% |
| Zydus Lifesciences Ltd | ₹1,12,020 Cr | 22.2 | 18.32% | ₹8,017 Cr | +14.7% |
| Laurus Labs Ltd | ₹1,11,310 Cr | 125.3 | 17.74% | ₹2,026 Cr | +125.7% |
| Cipla Limited | ₹1,07,048 Cr | 27.6 | 11.74% | ₹7,119 Cr | -14.7% |
| Dr.Reddys Lab | ₹1,02,611 Cr | 24.1 | 11.52% | ₹8,698 Cr | -0.9% |
| Aurobindo Pharma Ltd. | ₹95,910 Cr | 26.8 | 9.93% | ₹9,150 Cr | +41.7% |
| Mankind Pharma | ₹93,977 Cr | 48.7 | 12.45% | ₹4,031 Cr | -9.9% |
| Lupin Ltd | ₹89,426 Cr | 16.6 | 26.91% | ₹8,277 Cr | -1.1% |
| Ortin Laboratories Ltd | ₹11 Cr | -15.4 | -45.96% | ₹0 Cr | +8.4% |
Listed by market capitalisation. Ratios are shown for context only.
Ortin Laboratories Ltd is trading at ₹12.84, with a market capitalisation of ₹11 Cr.
Ortin Laboratories Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).
Ortin Laboratories Ltd has a P/E of -15.4 and a return on equity of -45.96%.
Ortin Laboratories Ltd is listed on the BSE under the scrip code 539287.
Ortin Laboratories Ltd's share price is up 8.4% over one year and down 13.3% over three months. Its 52-week range is ₹10.66 to ₹21.30.
In Q1 FY27, Ortin Laboratories Ltd reported revenue of ₹0 Cr and net profit of ₹-0 Cr, with basic EPS of ₹-0.42 (standalone, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.